420 related articles for article (PubMed ID: 31740490)
21. Inactivation of Cell Division Protein FtsZ by SulA Makes Lon Indispensable for the Viability of a ppGpp0 Strain of Escherichia coli.
Nazir A; Harinarayanan R
J Bacteriol; 2015 Dec; 198(4):688-700. PubMed ID: 26644431
[TBL] [Abstract][Full Text] [Related]
22. Trimethoprim-resistant Shigella and enterotoxigenic Escherichia coli strains in children in Thailand.
Chatkaeomorakot A; Echeverria P; Taylor DN; Seriwatana J; Leksomboon U
Pediatr Infect Dis J; 1987 Aug; 6(8):735-9. PubMed ID: 3313233
[TBL] [Abstract][Full Text] [Related]
23. A role for Lon protease in the control of the acid resistance genes of Escherichia coli.
Heuveling J; Possling A; Hengge R
Mol Microbiol; 2008 Jul; 69(2):534-47. PubMed ID: 18630346
[TBL] [Abstract][Full Text] [Related]
24. A mutation in the N domain of Escherichia coli lon stabilizes dodecamers and selectively alters degradation of model substrates.
Wohlever ML; Baker TA; Sauer RT
J Bacteriol; 2013 Dec; 195(24):5622-8. PubMed ID: 24123818
[TBL] [Abstract][Full Text] [Related]
25. The Escherichia coli replication inhibitor CspD is subject to growth-regulated degradation by the Lon protease.
Langklotz S; Narberhaus F
Mol Microbiol; 2011 Jun; 80(5):1313-25. PubMed ID: 21435040
[TBL] [Abstract][Full Text] [Related]
26. Multiple mutations modulate the function of dihydrofolate reductase in trimethoprim-resistant Streptococcus pneumoniae.
Maskell JP; Sefton AM; Hall LM
Antimicrob Agents Chemother; 2001 Apr; 45(4):1104-8. PubMed ID: 11257022
[TBL] [Abstract][Full Text] [Related]
27. Redundant in vivo proteolytic activities of Escherichia coli Lon and the ClpYQ (HslUV) protease.
Wu WF; Zhou Y; Gottesman S
J Bacteriol; 1999 Jun; 181(12):3681-7. PubMed ID: 10368141
[TBL] [Abstract][Full Text] [Related]
28. Saturation and specificity of the Lon protease of Escherichia coli.
Dervyn E; Canceill D; Huisman O
J Bacteriol; 1990 Dec; 172(12):7098-103. PubMed ID: 2254276
[TBL] [Abstract][Full Text] [Related]
29. Nucleotide sequence of dihydrofolate reductase genes from trimethoprim-resistant mutants of Escherichia coli. Evidence that dihydrofolate reductase interacts with another essential gene product.
Smith DR; Calvo JM
Mol Gen Genet; 1982; 187(1):72-8. PubMed ID: 6761546
[TBL] [Abstract][Full Text] [Related]
30. Defining the crucial domain and amino acid residues in bacterial Lon protease for DNA binding and processing of DNA-interacting substrates.
Karlowicz A; Wegrzyn K; Gross M; Kaczynska D; Ropelewska M; Siemiątkowska M; Bujnicki JM; Konieczny I
J Biol Chem; 2017 May; 292(18):7507-7518. PubMed ID: 28292931
[TBL] [Abstract][Full Text] [Related]
31. Directed evolution of trimethoprim resistance in Escherichia coli.
Watson M; Liu JW; Ollis D
FEBS J; 2007 May; 274(10):2661-71. PubMed ID: 17451440
[TBL] [Abstract][Full Text] [Related]
32. Development of antibacterial compounds that constrain evolutionary pathways to resistance.
Zhang Y; Chowdhury S; Rodrigues JV; Shakhnovich E
Elife; 2021 Jul; 10():. PubMed ID: 34279221
[TBL] [Abstract][Full Text] [Related]
33. An Integrated Proteomic Approach Uncovers Novel Substrates and Functions of the Lon Protease in Escherichia coli.
Arends J; Griego M; Thomanek N; Lindemann C; Kutscher B; Meyer HE; Narberhaus F
Proteomics; 2018 Jul; 18(13):e1800080. PubMed ID: 29710379
[TBL] [Abstract][Full Text] [Related]
34. Identification of the Molecular Mechanism of Trimethoprim Resistance in Listeria monocytogenes.
Korsak D; Krawczyk-Balska A
Foodborne Pathog Dis; 2017 Dec; 14(12):696-700. PubMed ID: 28910155
[TBL] [Abstract][Full Text] [Related]
35. Suppression of Δlon phenotypes in Escherichia coli by N-terminal DnaK peptides.
Kumaran N; Munavar MH
J Basic Microbiol; 2019 Mar; 59(3):302-313. PubMed ID: 30614541
[TBL] [Abstract][Full Text] [Related]
36. The emergence and mechanisms of trimethoprim resistance in Escherichia coli isolated from outpatients in Finland.
Heikkilä E; Renkonen OV; Sunila R; Uurasmaa P; Huovinen P
J Antimicrob Chemother; 1990 Feb; 25(2):275-83. PubMed ID: 2184160
[TBL] [Abstract][Full Text] [Related]
37. Alp, a suppressor of lon protease mutants in Escherichia coli.
Trempy JE; Gottesman S
J Bacteriol; 1989 Jun; 171(6):3348-53. PubMed ID: 2656652
[TBL] [Abstract][Full Text] [Related]
38. High-Order Epistasis in Catalytic Power of Dihydrofolate Reductase Gives Rise to a Rugged Fitness Landscape in the Presence of Trimethoprim Selection.
Tamer YT; Gaszek IK; Abdizadeh H; Batur TA; Reynolds KA; Atilgan AR; Atilgan C; Toprak E
Mol Biol Evol; 2019 Jul; 36(7):1533-1550. PubMed ID: 30982891
[TBL] [Abstract][Full Text] [Related]
39. Screening libraries for improved solubility: using E. coli dihydrofolate reductase as a reporter.
Liu JW; Ollis DL
Methods Mol Biol; 2013; 978():229-36. PubMed ID: 23423901
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of the type I and type II DHFR genes in trimethoprim-resistant urinary isolates of Escherichia coli from Greece.
Tsakris A; Johnson AP; Legakis NJ; Tzouvelekis LS
J Antimicrob Chemother; 1993 May; 31(5):665-71. PubMed ID: 8392996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
